Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.

Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1538-44. doi: 10.1016/j.pnpbp.2008.05.015. Epub 2008 May 25.

PMID:
18573585
[PubMed - indexed for MEDLINE]
2.

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

Oken BS, Storzbach DM, Kaye JA.

Arch Neurol. 1998 Nov;55(11):1409-15. Review.

PMID:
9823823
[PubMed - indexed for MEDLINE]
3.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis.

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217. Review.

PMID:
22002791
[PubMed - indexed for MEDLINE]
4.

Omega-3 fatty acids in depression: a review of three studies.

Osher Y, Belmaker RH.

CNS Neurosci Ther. 2009 Summer;15(2):128-33. Review.

PMID:
19499625
[PubMed - indexed for MEDLINE]
6.

Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?

Cederholm T, Palmblad J.

Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):150-5. doi: 10.1097/MCO.0b013e328335c40b. Review.

PMID:
20019606
[PubMed - indexed for MEDLINE]
7.

Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.

Yurko-Mauro K.

Curr Alzheimer Res. 2010 May;7(3):190-6. Review.

PMID:
20088810
[PubMed - indexed for MEDLINE]
8.

Target symptoms and outcome measures: cognition.

Kirk A.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S42-6. Review.

PMID:
17469681
[PubMed - indexed for MEDLINE]
9.

Essential fatty acids and the brain.

Haag M.

Can J Psychiatry. 2003 Apr;48(3):195-203. Review.

PMID:
12728744
[PubMed - indexed for MEDLINE]
10.

Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique.

Sontrop J, Campbell MK.

Prev Med. 2006 Jan;42(1):4-13. Epub 2005 Dec 7. Review.

PMID:
16337677
[PubMed - indexed for MEDLINE]
11.

L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial.

Burke WJ, Roccaforte WH, Wengel SP, Bayer BL, Ranno AE, Willcockson NK.

J Am Geriatr Soc. 1993 Nov;41(11):1219-25. Review.

PMID:
8227897
[PubMed - indexed for MEDLINE]
12.

Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.

Rockwood K.

J Neurol Neurosurg Psychiatry. 2004 May;75(5):677-85. Review. Erratum in: J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1086.

PMID:
15090558
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.

Emre M, Cummings JL, Lane RM.

J Alzheimers Dis. 2007 Jul;11(4):509-19. Review.

PMID:
17656830
[PubMed - indexed for MEDLINE]
14.

Omega-3 fatty acids and cognitive function in women.

Robinson JG, Ijioma N, Harris W.

Womens Health (Lond Engl). 2010 Jan;6(1):119-34. doi: 10.2217/whe.09.75. Review.

PMID:
20088735
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.

Assisi A, Banzi R, Buonocore C, Capasso F, Di Muzio V, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S.

Int Clin Psychopharmacol. 2006 Nov;21(6):319-36. Review.

PMID:
17012979
[PubMed - indexed for MEDLINE]
16.

Measuring cognitive change in Alzheimer's disease clinical drug trials.

Harrison JE.

J Nutr Health Aging. 2007 Jul-Aug;11(4):327-9. Review.

PMID:
17653492
[PubMed - indexed for MEDLINE]
17.

Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective.

Broich K.

Int Psychogeriatr. 2007 Jun;19(3):509-24. Epub 2007 Apr 16. Review.

PMID:
17433121
[PubMed - indexed for MEDLINE]
18.

Alzhemed: a potential treatment for Alzheimer's disease.

Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D.

Curr Alzheimer Res. 2007 Sep;4(4):473-8. Review.

PMID:
17908052
[PubMed - indexed for MEDLINE]
19.

Diagnosis and treatment of Alzheimer's disease.

Grossberg GT.

J Clin Psychiatry. 2003;64 Suppl 9:3-6. Review.

PMID:
12934967
[PubMed - indexed for MEDLINE]
20.

Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.

Emsley R, Oosthuizen P, van Rensburg SJ.

CNS Drugs. 2003;17(15):1081-91. Review.

PMID:
14661986
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk